2012/2 GaBI Journal Table of Contents

Contents

Editor’s Letter

What to look forward to in GaBI Journal, 2012, issue 2

Editorial

Equal protection under the law: Children and the Best Pharmaceuticals for Children Act

Regulatory

Tighter EU rules on pharmacovigilance for biologicals

Review Article

What lessons can be learned from the launch of generic clopidogrel?

Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach

Perspective

Promoting access to biosimilars: a public−private partnership model for biosimilar development in underserved populations

Generic clopidogrel–the medicines agency’s perspective

Special Report

The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview

Guidelines

Generics substitution in primary care: summary of the Dutch community pharmacies guidelines

Readers’ Comments

Abstracted Scientific Content

Oncologists urged to embrace biosimilars to help control spiralling costs of cancer care

Source URL: https://gabi-journal.net/20122-gabi-journal-table-of-contents.html